Sanofi: Malaria trials
The registry lists 11 Malaria studies with Sanofi as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 3Phase 3 2Phase 4 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated MalariaTerminatedNCT01445938Phase 2
- Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax MalariaCompletedNCT01378286Phase 3
- Artesunate Plus Amodiaquine in Malaria in Cote d'IvoireCompletedNCT01023399Phase 4
- Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.TerminatedNCT00739206Phase 2
- Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria AttacksCompletedNCT00699920Phase 4
- A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated MalariaCompletedNCT00563914Phase 1/2
- Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria AttacksCompletedNCT00540410Phase 4
- ACT MALI: Treatment of Malaria Based on Combination TherapiesCompletedNCT00452907Phase 4
- Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLeranceCompletedNCT00445796Phase 4
- Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted ConditionsCompletedNCT00386503Phase 1
- ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum MalariaCompletedNCT00316329Phase 3